Ascites-derived circulating microRNAs as potential diagnostic biomarkers of gastric cancer-associated malignant ascites

被引：0
|
作者：
Han, H. S. [1 ]
Chae, H. B. [1 ]
Yun, J. [2 ]
Kim, H. J. [3 ]
Go, S-I. [3 ]
Lee, W. S. [3 ]
Bae, W. K. [4 ]
Cho, S. H. [4 ]
Song, E. -K. [5 ]
机构：
[1] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea
[2] Cheongju Univ, Coll Sci Engn, Dept Pharmaceut Engn, Cheongju, South Korea
[3] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Jinju, South Korea
[4] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea
[5] Chonbuk Natl Univ, Med Sch, Dept Internal Med, Jeonju, South Korea
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
167P
引用
收藏
页码：52 / +
页数：2
相关论文
共 50 条
  • [31] Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM
    Runz, Steffen
    Keller, Sascha
    Rupp, Christian
    Stoeck, Alexander
    Issa, Yasmin
    Koensgen, Dominique
    Mustea, Alexander
    Sehouli, Jalid
    Kristiansen, Glen
    Altevogt, Peter
    GYNECOLOGIC ONCOLOGY, 2007, 107 (03) : 563 - 571
  • [32] Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells
    Wei, Mingtian
    Yang, Tinghan
    Chen, Xiangzheng
    Wu, Yangping
    Deng, Xiangbing
    He, Wanbin
    Yang, Jinliang
    Wang, Ziqiang
    ONCOTARGET, 2017, 8 (26) : 42262 - 42271
  • [33] Circulating microRNAs as diagnostic biomarkers for pancreatic cancer
    Le Large, Tessa Y. S.
    Meijer, Laura L.
    Prado, Mireia Mato
    Kazemier, Geert
    Frampton, Adam E.
    Giovannetti, Elisa
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2015, 15 (12) : 1525 - 1529
  • [34] Evaluation and treatment of malignant ascites secondary to gastric cancer
    Hiromichi Maeda
    Michiya Kobayashi
    Junichi Sakamoto
    World Journal of Gastroenterology, 2015, 21 (39) : 10936 - 10947
  • [35] Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites
    Hidenori Tamegai
    Teruo Kaiga
    Mitsugu Kochi
    Masashi Fujii
    Noriaki Kanamori
    Yoshiaki Mihara
    Tomoya Funada
    Hiroko Shimizu
    Daijo Jinno
    Tadatoshi Takayama
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 727 - 731
  • [36] Evaluation and treatment of malignant ascites secondary to gastric cancer
    Maeda, Hiromichi
    Kobayashi, Michiya
    Sakamoto, Junichi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (39) : 10936 - 10947
  • [37] Clinicopathological characteristics and prognosis of gastric cancer with malignant ascites
    Fang, Nian
    Zhang, Hui-Qing
    He, Bo
    Xie, Mei
    Lu, Shan
    Wan, Yi-Ye
    Wang, Nong-Rong
    TUMOR BIOLOGY, 2014, 35 (04) : 3261 - 3268
  • [38] Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites
    Tamegai, Hidenori
    Kaiga, Teruo
    Kochi, Mitsugu
    Fujii, Masashi
    Kanamori, Noriaki
    Mihara, Yoshiaki
    Funada, Tomoya
    Shimizu, Hiroko
    Jinno, Daijo
    Takayama, Tadatoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 727 - 731
  • [39] AGGRESSIVE IMMUNOCHEMOTHERAPY FOR GASTRIC-CANCER WITH MALIGNANT ASCITES
    IWASAKI, K
    TORISU, M
    HANADA, M
    YOSHIDA, T
    NEW HORIZONS OF TUMOR IMMUNOTHERAPY, 1989, 852 : 569 - 580
  • [40] MicroRNAs: Promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential
    Matuszcak, Christiane
    Haier, Joerg
    Hummel, Richard
    Lindner, Kirsten
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (38) : 13658 - 13666
12345